These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. House calls. Why is my doctor recommending that I be treated for polycythemia vera even though I feel fine? Johns Hopkins Med Lett Health After 50; 2002 May; 14(3):8. PubMed ID: 12004839 [No Abstract] [Full Text] [Related]
23. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T; Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [TBL] [Abstract][Full Text] [Related]
25. [Rheologic properties of the erythrocytes and hemostatic system in patients with polycythemia vera]. Bessmel'tsev SS; Fedorova ZD; Abdulkadyrov KM Gematol Transfuziol; 1989 Nov; 34(11):29-33. PubMed ID: 2612861 [TBL] [Abstract][Full Text] [Related]
26. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Michiels JJ; Berneman Z; Schroyens W; van Urk H Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947 [TBL] [Abstract][Full Text] [Related]
27. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature]. Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387 [TBL] [Abstract][Full Text] [Related]
28. [Blood pressure and the prevalence of hypertension in polycythemia vera and secondary polyglobulia]. Lüscher T; Vetter H; Heilmann E; Rhyner K; Grimm J; Keller E; Voss HM; Streuli RA; Studer A; Vetter W Schweiz Rundsch Med Prax; 1983 Mar; 72(12):388-95. PubMed ID: 6856565 [No Abstract] [Full Text] [Related]
29. [Clinical analysis of 185 patients with polycythemia vera]. Bai J; Shao Z; Jing L; Liu H; Shi J; Zhao M; Fu R; He G; Sun J; Jia H; Qian L; Yang T; Yang C Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):578-80. PubMed ID: 12482341 [TBL] [Abstract][Full Text] [Related]
30. [A case of polycythemia vera with a neurological syndrome]. Machura B; Piestrak J; Nowak S Wiad Lek; 1968 Jun; 21(11):963-6. PubMed ID: 5669418 [No Abstract] [Full Text] [Related]
35. [Disorders of the reparative process in polycythemia vera]. Ternovoĭ KS Klin Med (Mosk); 1968 Feb; 46(2):65-7. PubMed ID: 5746978 [No Abstract] [Full Text] [Related]
36. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481 [TBL] [Abstract][Full Text] [Related]
37. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications. Cacciola RR; Di Francesco E; Giustolisi R; Cacciola E Haematologica; 2002 Jul; 87(7):774-5. PubMed ID: 12091131 [TBL] [Abstract][Full Text] [Related]
40. [Clinical aspects and therapy of hyperviscosity syndrome. Clinical, viscosimetric and plethysmographic studies on the efficacy and duration of the effects of erythrocytapheresis and plasmapheresis in polycythemia vera and monoclonal gammopathies]. van den Berg E; Haedicke C; Sgries B; Stangel W; Altmann S; Hartmann F Vasa Suppl; 1983; 10():1-37. PubMed ID: 6340361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]